193 related articles for article (PubMed ID: 19836067)
41. Performance of OncoE6
Ndizeye Z; Menon S; Van Geertruyden JP; Sauvaget C; Jacquemyn Y; Bogers JP; Benoy I; Vanden Broeck D
BMJ Open; 2019 Sep; 9(9):e029088. PubMed ID: 31494606
[TBL] [Abstract][Full Text] [Related]
42. Liquid-based cytology: do ancillary techniques enhance detection of epithelial abnormalities?
Mishra S; Husain N; Awasthi NP; Pradeep Y; Roohi R; Saxena S
Arch Gynecol Obstet; 2018 Jul; 298(1):159-169. PubMed ID: 29728850
[TBL] [Abstract][Full Text] [Related]
43. Minichromosome Maintenance Complex (MCM) Genes Profiling and MCM2 Protein Expression in Cervical Cancer Development.
Kaur G; Balasubramaniam SD; Lee YJ; Balakrishnan V; Oon CE
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3043-3049. PubMed ID: 31653153
[TBL] [Abstract][Full Text] [Related]
44. [Promoter methylation of DAPK gene in cervical carcinoma].
Zhao XL; Meng ZY; Qiao YH; Zhang HL
Ai Zheng; 2008 Sep; 27(9):919-23. PubMed ID: 18799028
[TBL] [Abstract][Full Text] [Related]
45. Septin9 DNA methylation as a promising biomarker for cervical cancer.
Bu Q; Luo X; He L; Ma J; He S; Lei W; Zhou W; Deng H; Lin Y; Zhang L; Hong X
J Obstet Gynaecol; 2023 Dec; 43(1):2151356. PubMed ID: 36476308
[TBL] [Abstract][Full Text] [Related]
46. Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
Obermann EC; Savic Prince S; Barascud A; Grilli B; Herzog M; Kaup D; Cathomas G; Frey Tirri B; Zlobec I; Wight E; Bubendorf L
Cancer Cytopathol; 2013 Aug; 121(8):423-31. PubMed ID: 23408758
[TBL] [Abstract][Full Text] [Related]
47. TIMP-2 gene methylation in cervical precursor and invasive lesions.
Furtado Y; Almeida G; Silveira FA; Silva KS; Maldonado P; do Val IC; Cavalcanti S; L MA; Carvalho Mda G
Exp Mol Pathol; 2015 Feb; 98(1):119-23. PubMed ID: 25579181
[TBL] [Abstract][Full Text] [Related]
48. HPV infection and p16 promoter methylation as predictors of ASC-US/LSIL progression.
Lee H; Lee EJ
Cancer Cytopathol; 2016 Jan; 124(1):58-65. PubMed ID: 26335500
[TBL] [Abstract][Full Text] [Related]
49. Implications of continued upregulation of p16(INK4a) through the evolution from high-grade squamous intraepithelial lesion to invasive squamous carcinoma of the cervix.
Cheah PL; Looi LM; Mun KS; Abdoul Rahman N; Teoh KH
Malays J Pathol; 2011 Dec; 33(2):83-7. PubMed ID: 22299207
[TBL] [Abstract][Full Text] [Related]
50. [Accuracy of liquid-based cytology in diagnosis of high-grade squamous cervical intraepithelial neoplasia].
Li M; Mei P; Luo DL; Wang XB; Liu YH
Zhonghua Bing Li Xue Za Zhi; 2012 Apr; 41(4):265-8. PubMed ID: 22800524
[TBL] [Abstract][Full Text] [Related]
51. Detection of hypermethylated genes in women with and without cervical neoplasia.
Feng Q; Balasubramanian A; Hawes SE; Toure P; Sow PS; Dem A; Dembele B; Critchlow CW; Xi L; Lu H; McIntosh MW; Young AM; Kiviat NB
J Natl Cancer Inst; 2005 Feb; 97(4):273-82. PubMed ID: 15713962
[TBL] [Abstract][Full Text] [Related]
52. Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
Ge Y; Christensen P; Luna E; Armylagos D; Schwartz MR; Mody DR
Cancer Cytopathol; 2017 Aug; 125(8):652-657. PubMed ID: 28574670
[TBL] [Abstract][Full Text] [Related]
53. Aberrant gene-specific DNA methylation signature analysis in cervical cancer.
Bhat S; Kabekkodu SP; Varghese VK; Chakrabarty S; Mallya SP; Rotti H; Pandey D; Kushtagi P; Satyamoorthy K
Tumour Biol; 2017 Mar; 39(3):1010428317694573. PubMed ID: 28351298
[TBL] [Abstract][Full Text] [Related]
54. [Expression and clinical significance of Dyrk1b in the specimens and cells of cervical lesions].
Lin J; Zhang P; Pang L; Chen J; Sun W; Qi W; Lyu Y; Guan H; Gao J
Zhonghua Fu Chan Ke Za Zhi; 2016 Jan; 51(1):40-5. PubMed ID: 26899006
[TBL] [Abstract][Full Text] [Related]
55. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM
Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662
[TBL] [Abstract][Full Text] [Related]
56. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
Zhou F; Pulinthanathu R; Elgert P; Cangiarella J; Simsir A
Diagn Cytopathol; 2015 May; 43(5):381-7. PubMed ID: 25546355
[TBL] [Abstract][Full Text] [Related]
57. The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion.
Nasser SM; Cibas ES; Crum CP; Faquin WC
Cancer; 2003 Oct; 99(5):272-6. PubMed ID: 14579293
[TBL] [Abstract][Full Text] [Related]
58. Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix.
van der Meide WF; Snellenberg S; Meijer CJ; Baalbergen A; Helmerhorst TJ; van der Sluis WB; Snijders PJ; Steenbergen RD
Gynecol Oncol; 2011 Oct; 123(1):116-22. PubMed ID: 21726894
[TBL] [Abstract][Full Text] [Related]
59. [Pregnancy related cervical cytological changes and clinical management].
Ma L; Bian ML; Liu J; Wang XH; Pang CH; Chen Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):84-7. PubMed ID: 21426763
[TBL] [Abstract][Full Text] [Related]
60. Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis.
Huang J; Luo JY; Tan HZ
PLoS One; 2019; 14(10):e0222772. PubMed ID: 31574102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
